Published Online First

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Smolen, J
Schoels, M
Nishimoto, N
Breedveld, F
Burmester, G
Dougados, M
Emery, P
Ferraccioli, G
Gabay, C
Gibofsky, A
Gomez-Reino, J
Jones, Graeme
Kvien, T
Murakami, M
Betteridge, N
Bingham, C
Bykerk, V
Choy, Ernest
Combe, B
Cutolo, M
Graninger, W
Lanas, A
Martin-Mola, E
Montecucco, C
Ostergaard, M
Pavelka, K
Rubbert-Roth, A
Sattar, N
Scholte-Voshaar, M
Tanaka, Y
Trauner, M
Valentini, G
Winthrop, K
de Wit, M
van der Heijde, D

April 2013

Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juvenile idiopath...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Smolen, J
Schoels, M
Nishimoto, N
Breedveld, F
Burmester, G
Dougados, M
Emery, P
Ferraccioli, G
Gabay, C
Gibofsky, A
Gomez-Reino, J
Jones, Graeme
Kvien, T
Murakami, M
Betteridge, N
Bingham, C
Bykerk, V
Choy, Ernest
Combe, B
Cutolo, M
Graninger, W
Lanas, A
Martin-Mola, E
Montecucco, C
Ostergaard, M
Pavelka, K
Rubbert-Roth, A
Sattar, N
Scholte-Voshaar, M
Tanaka, Y
Trauner, M
Valentini, G
Winthrop, K
de Wit, M
van der Heijde, D

April 2013

Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juvenile idiopath...

Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement

Schoels, Monika M
van der Heijde, Désirée
Breedveld, Ferdinand C
Burmester, Gerd R
Dougados, Maxime
Emery, Paul
Ferraccioli, Gianfranco
Gabay, Cem
Gibofsky, Allan
Gomez-Reino, Juan Jesus
Jones, Graeme
Kvien, Tore K
Murakami, Miho
Murikama, Miho M
Nishimoto, Norihiro
Smolen, Josef S

January 2013

Suppression of the immunoinflammatory cascade by targeting interleukin 6 (IL-6) mediated effects con...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Smolen, Js
Schoels, Mm
Nishimoto, N
Breedveld, Fc
Burmester, Gr
Dougados, M
Emery, P
Ferraccioli, Gianfranco (ORCID:0000-0001-6246-2428)
Gabay, C
Gibofsky, A
Gomez Reino, Jj
Jones, G
Kvien, Tk
Murakami, M
Betteridge, N
Bingham, Co
Bykerk, V
Choy, Eh
Combe, B
Cutolo, M
Graninger, W
Lanas, A
Martin Mola, E
Montecucco, C
Ostergaard, M
Pavelka, K
Rubbert Roth, A
Sattar, N
Scholte Voshaar, M
Tanaka, Y
Trauner, M
Valentini, G
Winthrop, Kl
De Wit, M
Van Der Heijde, D.

January 2013

Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juvenile idiopath...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Ferraccioli, Gianfranco (ORCID:0000-0001-6246-2428)

January 2013

Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juvenile idiopath...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Smolen, Josef S
Schoels, Monika M
Nishimoto, Norihiro
Breedveld, Ferdinand C
Burmester, Gerd R
Dougados, Maxime
Emery, Paul
Ferraccioli, Gianfranco
Gabay, Cem
Gibofsky, Allan
Gomez-Reino, Juan Jesus
Jones, Graeme
Kvien, Tore K
Murakami, Miho
Betteridge, Neil
Bingham, Clifton O (3rd)
Bykerk, Vivian
Choy, Ernest H
Combe, Bernard
Cutolo, Maurizio
Graninger, Winfried
Lanas, Angel
Martin-Mola, Emilio
Montecucco, Carlomaurizio
Ostergaard, Mikkel
Pavelka, Karel
Rubbert-Roth, Andrea
Sattar, Naveed
Scholte-Voshaar, Marieke
Tanaka, Yoshiya
Trauner, Michael
Valentini, Gabriele
Winthrop, Kevin L
de Wit, Maarten
van der Heijde, Désirée

January 2013

Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juvenile idiopath...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Smolen, J.S.
Schoels, M.M.
Nishimoto, N.
Breedveld, F.C.
Burmester, G.R.
Dougados, M.
Emery, P.
Ferraccioli, G.
Gabay, C.
Gibofsky, A.
Gomez-Reino, J.J.
Jones, G.
Kvien, T.K.
Murakami, M.
Betteridge, N.
Bingham, C.O.
Bykerk, V.
Choy, E.H.
Combe, B.
Cutolo, M.
Graninger, W.
Lanas, A.
Martin-Mola, E.
Montecucco, C.
Ostergaard, M.
Pavelka, K.
Rubbert-Roth, A.
Sattar, N.
Scholte-Voshaar, M.
Tanaka, Y.
Trauner, M.
Valentini, G.
Winthrop, K.L.
de Wit, M.
van der Heijde, D.

April 2013

Background: Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juven...

Correspondence to

January 2012

Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic disea...

Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

Aletaha, D.
Kerschbaumer, A.
Kastrati, K.
Dejaco, C.
Dougados, M.
McInnes, I.B.
Sattar, N.
Stamm, T.A.
Takeuchi, T.
Trauner, M.
Heijde, D. van der
Voshaar, M.
Winthrop, K.L.
Ravelli, A.
Betteridge, N.
Burmester, G.R.R.
Bijlsma, J.W.J.
Bykerk, V.
Caporali, R.
Choy, E.H.
Codreanu, C.
Combe, B.
Crow, M.K.
Wit, M. de
Emery, P.
Fleischmann, R.M.
Gabay, C.
Hetland, M.L.
Hyrich, K.L.
Iagnocco, A.
Isaacs, J.D.
Kremer, J.M.
Mariette, X.
Merkel, P.
Mysler, E.F.
Nash, P.
Nurmohamed, M.T.
Pavelka, K.
Poor, G.
Rubbert-Roth, A.
Schulze-Koops, H.
Strangfeld, A.
Tanaka, Y.
Smolen, J.S.

August 2022

Background Targeting interleukin (IL)-6 has become a major therapeutic strategy in the treatment of ...

Correspondence to

January 2012

Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic disea...

Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

Aletaha, Daniel
Kerschbaumer, Andreas
Kastrati, Kastriot
Dejaco, Christian
Dougados, Maxime
McInnes, Iain B.
Sattar, Naveed
Stamm, Tanja A.
Takeuchi, Tsutomu
Trauner, Michael
van der Heijde, D. sirée
Voshaar, Marieke
Winthrop, Kevin L.
Ravelli, Angelo
Betteridge, Neil
Burmester, Gerd-R. diger R.
Bijlsma, Johannes W. J.
Bykerk, Vivian
Caporali, Roberto
Choy, Ernest H.
Codreanu, Catalin
Combe, Bernard
Crow, Mary K.
de Wit, Maarten
Emery, Paul
Fleischmann, Roy M.
Gabay, Cem
Hetland, Merete Lund
Hyrich, Kimme L.
Iagnocco, Annamaria
Isaacs, John D.
Kremer, Joel M.
Mariette, Xavier
Merkel, Peter
Mysler, Eduardo F.
Nash, Peter
Nurmohamed, Michael T.
Pavelka, Karel
Poor, Gyula
Rubbert-Roth, Andrea
Schulze-Koops, Hendrik
Strangfeld, Anja
Tanaka, Yoshiya
Smolen, Josef S.

January 2022

Background: Targeting interleukin (IL)-6 has become a major therapeutic strategy in the treatment of...

Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

Aletaha, Daniel
Kerschbaumer, Andreas
Kastrati, Kastriot
Dejaco, Christian
Dougados, Maxime
McInnes, Iain B.
Sattar, Naveed
Stamm, Tanja A.
Takeuchi, Tsutomu
Trauner, Michael
Van Der Heijde, Désirée
Voshaar, Marieke
Winthrop, Kevin L.
Ravelli, Angelo
Betteridge, Neil
Burmester, Gerd Rüdiger R.
Bijlsma, Johannes W.J.
Bykerk, Vivian
Caporali, Roberto
Choy, Ernest H.
Codreanu, Catalin
Combe, Bernard
Crow, Mary K.
De Wit, Maarten
Emery, Paul
Fleischmann, Roy M.
Gabay, Cem
Hetland, Merete Lund
Hyrich, Kimme L.
Iagnocco, Annamaria
Isaacs, John D.
Kremer, Joel M.
Mariette, Xavier
Merkel, Peter
Mysler, Eduardo F.
Nash, Peter
Nurmohamed, Michael T.
Pavelka, Karel
Poor, Gyula
Rubbert-Roth, Andrea
Schulze-Koops, Hendrik
Strangfeld, Anja
Tanaka, Yoshiya
Smolen, Josef S.

August 2022

Background: Targeting interleukin (IL)-6 has become a major therapeutic strategy in the treatment of...

Available at:

January 2012

Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic disea...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions.

J. S. Smolen
M. M. Schoels
N. Nishimoto
F. C. Breedveld
G. R. Burmester
M. Dougados
P. Emery
G. Ferraccioli
C. Gabay
A. Gibofsky
J. J. Gomez Reino
G. Jones
T. K. Kvien
M. Murakami
N. Betteridge
C. O. Bingham
V. Bykerk
E. H. Choy
B. Combe
M. Cutolo
W. Graninger
A. Lanas
E. Martin Mola
M. Ostergaard
K. Pavelka
A. Rubbert Roth
N. Sattar
M. Scholte Voshaar
Y. Tanaka
M. Trauner
G. Valentini
K. L. Winthrop
M. d. Wit
D. v. der
MONTECUCCO, CARLOMAURIZIO

January 2013

BACKGROUND: Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juven...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Smolen, J
Schoels, M
Nishimoto, N
Breedveld, F
Burmester, G
Dougados, M
Emery, P
Ferraccioli, G
Gabay, C
Gibofsky, A
Gomez-Reino, J
Jones, Graeme
Kvien, T
Murakami, M
Betteridge, N
Bingham, C
Bykerk, V
Choy, Ernest
Combe, B
Cutolo, M
Graninger, W
Lanas, A
Martin-Mola, E
Montecucco, C
Ostergaard, M
Pavelka, K
Rubbert-Roth, A
Sattar, N
Scholte-Voshaar, M
Tanaka, Y
Trauner, M
Valentini, G
Winthrop, K
de Wit, M
van der Heijde, D

April 2013

Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juvenile idiopath...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Smolen, J
Schoels, M
Nishimoto, N
Breedveld, F
Burmester, G
Dougados, M
Emery, P
Ferraccioli, G
Gabay, C
Gibofsky, A
Gomez-Reino, J
Jones, Graeme
Kvien, T
Murakami, M
Betteridge, N
Bingham, C
Bykerk, V
Choy, Ernest
Combe, B
Cutolo, M
Graninger, W
Lanas, A
Martin-Mola, E
Montecucco, C
Ostergaard, M
Pavelka, K
Rubbert-Roth, A
Sattar, N
Scholte-Voshaar, M
Tanaka, Y
Trauner, M
Valentini, G
Winthrop, K
de Wit, M
van der Heijde, D

April 2013

Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juvenile idiopath...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Smolen, J
Schoels, M
Nishimoto, N
Breedveld, F
Burmester, G
Dougados, M
Emery, P
Ferraccioli, G
Gabay, C
Gibofsky, A
Gomez-Reino, J
Jones, Graeme
Kvien, T
Murakami, M
Betteridge, N
Bingham, C
Bykerk, V
Choy, Ernest
Combe, B
Cutolo, M
Graninger, W
Lanas, A
Martin-Mola, E
Montecucco, C
Ostergaard, M
Pavelka, K
Rubbert-Roth, A
Sattar, N
Scholte-Voshaar, M
Tanaka, Y
Trauner, M
Valentini, G
Winthrop, K
de Wit, M
van der Heijde, D

April 2013

Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juvenile idiopath...

Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement

Schoels, Monika M
van der Heijde, Désirée
Breedveld, Ferdinand C
Burmester, Gerd R
Dougados, Maxime
Emery, Paul
Ferraccioli, Gianfranco
Gabay, Cem
Gibofsky, Allan
Gomez-Reino, Juan Jesus
Jones, Graeme
Kvien, Tore K
Murakami, Miho
Murikama, Miho M
Nishimoto, Norihiro
Smolen, Josef S

January 2013

Suppression of the immunoinflammatory cascade by targeting interleukin 6 (IL-6) mediated effects con...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Smolen, Js
Schoels, Mm
Nishimoto, N
Breedveld, Fc
Burmester, Gr
Dougados, M
Emery, P
Ferraccioli, Gianfranco (ORCID:0000-0001-6246-2428)
Gabay, C
Gibofsky, A
Gomez Reino, Jj
Jones, G
Kvien, Tk
Murakami, M
Betteridge, N
Bingham, Co
Bykerk, V
Choy, Eh
Combe, B
Cutolo, M
Graninger, W
Lanas, A
Martin Mola, E
Montecucco, C
Ostergaard, M
Pavelka, K
Rubbert Roth, A
Sattar, N
Scholte Voshaar, M
Tanaka, Y
Trauner, M
Valentini, G
Winthrop, Kl
De Wit, M
Van Der Heijde, D.

January 2013

Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juvenile idiopath...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Ferraccioli, Gianfranco (ORCID:0000-0001-6246-2428)

January 2013

Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juvenile idiopath...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Smolen, Josef S
Schoels, Monika M
Nishimoto, Norihiro
Breedveld, Ferdinand C
Burmester, Gerd R
Dougados, Maxime
Emery, Paul
Ferraccioli, Gianfranco
Gabay, Cem
Gibofsky, Allan
Gomez-Reino, Juan Jesus
Jones, Graeme
Kvien, Tore K
Murakami, Miho
Betteridge, Neil
Bingham, Clifton O (3rd)
Bykerk, Vivian
Choy, Ernest H
Combe, Bernard
Cutolo, Maurizio
Graninger, Winfried
Lanas, Angel
Martin-Mola, Emilio
Montecucco, Carlomaurizio
Ostergaard, Mikkel
Pavelka, Karel
Rubbert-Roth, Andrea
Sattar, Naveed
Scholte-Voshaar, Marieke
Tanaka, Yoshiya
Trauner, Michael
Valentini, Gabriele
Winthrop, Kevin L
de Wit, Maarten
van der Heijde, Désirée

January 2013

Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juvenile idiopath...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Smolen, J.S.
Schoels, M.M.
Nishimoto, N.
Breedveld, F.C.
Burmester, G.R.
Dougados, M.
Emery, P.
Ferraccioli, G.
Gabay, C.
Gibofsky, A.
Gomez-Reino, J.J.
Jones, G.
Kvien, T.K.
Murakami, M.
Betteridge, N.
Bingham, C.O.
Bykerk, V.
Choy, E.H.
Combe, B.
Cutolo, M.
Graninger, W.
Lanas, A.
Martin-Mola, E.
Montecucco, C.
Ostergaard, M.
Pavelka, K.
Rubbert-Roth, A.
Sattar, N.
Scholte-Voshaar, M.
Tanaka, Y.
Trauner, M.
Valentini, G.
Winthrop, K.L.
de Wit, M.
van der Heijde, D.

April 2013

Background: Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juven...

Correspondence to

January 2012

Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic disea...

Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

Aletaha, D.
Kerschbaumer, A.
Kastrati, K.
Dejaco, C.
Dougados, M.
McInnes, I.B.
Sattar, N.
Stamm, T.A.
Takeuchi, T.
Trauner, M.
Heijde, D. van der
Voshaar, M.
Winthrop, K.L.
Ravelli, A.
Betteridge, N.
Burmester, G.R.R.
Bijlsma, J.W.J.
Bykerk, V.
Caporali, R.
Choy, E.H.
Codreanu, C.
Combe, B.
Crow, M.K.
Wit, M. de
Emery, P.
Fleischmann, R.M.
Gabay, C.
Hetland, M.L.
Hyrich, K.L.
Iagnocco, A.
Isaacs, J.D.
Kremer, J.M.
Mariette, X.
Merkel, P.
Mysler, E.F.
Nash, P.
Nurmohamed, M.T.
Pavelka, K.
Poor, G.
Rubbert-Roth, A.
Schulze-Koops, H.
Strangfeld, A.
Tanaka, Y.
Smolen, J.S.

August 2022

Background Targeting interleukin (IL)-6 has become a major therapeutic strategy in the treatment of ...

Correspondence to

January 2012

Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic disea...

Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

Aletaha, Daniel
Kerschbaumer, Andreas
Kastrati, Kastriot
Dejaco, Christian
Dougados, Maxime
McInnes, Iain B.
Sattar, Naveed
Stamm, Tanja A.
Takeuchi, Tsutomu
Trauner, Michael
van der Heijde, D. sirée
Voshaar, Marieke
Winthrop, Kevin L.
Ravelli, Angelo
Betteridge, Neil
Burmester, Gerd-R. diger R.
Bijlsma, Johannes W. J.
Bykerk, Vivian
Caporali, Roberto
Choy, Ernest H.
Codreanu, Catalin
Combe, Bernard
Crow, Mary K.
de Wit, Maarten
Emery, Paul
Fleischmann, Roy M.
Gabay, Cem
Hetland, Merete Lund
Hyrich, Kimme L.
Iagnocco, Annamaria
Isaacs, John D.
Kremer, Joel M.
Mariette, Xavier
Merkel, Peter
Mysler, Eduardo F.
Nash, Peter
Nurmohamed, Michael T.
Pavelka, Karel
Poor, Gyula
Rubbert-Roth, Andrea
Schulze-Koops, Hendrik
Strangfeld, Anja
Tanaka, Yoshiya
Smolen, Josef S.

January 2022

Background: Targeting interleukin (IL)-6 has become a major therapeutic strategy in the treatment of...

Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

Aletaha, Daniel
Kerschbaumer, Andreas
Kastrati, Kastriot
Dejaco, Christian
Dougados, Maxime
McInnes, Iain B.
Sattar, Naveed
Stamm, Tanja A.
Takeuchi, Tsutomu
Trauner, Michael
Van Der Heijde, Désirée
Voshaar, Marieke
Winthrop, Kevin L.
Ravelli, Angelo
Betteridge, Neil
Burmester, Gerd Rüdiger R.
Bijlsma, Johannes W.J.
Bykerk, Vivian
Caporali, Roberto
Choy, Ernest H.
Codreanu, Catalin
Combe, Bernard
Crow, Mary K.
De Wit, Maarten
Emery, Paul
Fleischmann, Roy M.
Gabay, Cem
Hetland, Merete Lund
Hyrich, Kimme L.
Iagnocco, Annamaria
Isaacs, John D.
Kremer, Joel M.
Mariette, Xavier
Merkel, Peter
Mysler, Eduardo F.
Nash, Peter
Nurmohamed, Michael T.
Pavelka, Karel
Poor, Gyula
Rubbert-Roth, Andrea
Schulze-Koops, Hendrik
Strangfeld, Anja
Tanaka, Yoshiya
Smolen, Josef S.

August 2022

Background: Targeting interleukin (IL)-6 has become a major therapeutic strategy in the treatment of...

Available at:

January 2012

Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic disea...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions.

J. S. Smolen
M. M. Schoels
N. Nishimoto
F. C. Breedveld
G. R. Burmester
M. Dougados
P. Emery
G. Ferraccioli
C. Gabay
A. Gibofsky
J. J. Gomez Reino
G. Jones
T. K. Kvien
M. Murakami
N. Betteridge
C. O. Bingham
V. Bykerk
E. H. Choy
B. Combe
M. Cutolo
W. Graninger
A. Lanas
E. Martin Mola
M. Ostergaard
K. Pavelka
A. Rubbert Roth
N. Sattar
M. Scholte Voshaar
Y. Tanaka
M. Trauner
G. Valentini
K. L. Winthrop
M. d. Wit
D. v. der
MONTECUCCO, CARLOMAURIZIO

January 2013

BACKGROUND: Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juven...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Smolen, J
Schoels, M
Nishimoto, N
Breedveld, F
Burmester, G
Dougados, M
Emery, P
Ferraccioli, G
Gabay, C
Gibofsky, A
Gomez-Reino, J
Jones, Graeme
Kvien, T
Murakami, M
Betteridge, N
Bingham, C
Bykerk, V
Choy, Ernest
Combe, B
Cutolo, M
Graninger, W
Lanas, A
Martin-Mola, E
Montecucco, C
Ostergaard, M
Pavelka, K
Rubbert-Roth, A
Sattar, N
Scholte-Voshaar, M
Tanaka, Y
Trauner, M
Valentini, G
Winthrop, K
de Wit, M
van der Heijde, D

April 2013

Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juvenile idiopath...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Smolen, J
Schoels, M
Nishimoto, N
Breedveld, F
Burmester, G
Dougados, M
Emery, P
Ferraccioli, G
Gabay, C
Gibofsky, A
Gomez-Reino, J
Jones, Graeme
Kvien, T
Murakami, M
Betteridge, N
Bingham, C
Bykerk, V
Choy, Ernest
Combe, B
Cutolo, M
Graninger, W
Lanas, A
Martin-Mola, E
Montecucco, C
Ostergaard, M
Pavelka, K
Rubbert-Roth, A
Sattar, N
Scholte-Voshaar, M
Tanaka, Y
Trauner, M
Valentini, G
Winthrop, K
de Wit, M
van der Heijde, D

April 2013

Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juvenile idiopath...

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Smolen, J
Schoels, M
Nishimoto, N
Breedveld, F
Burmester, G
Dougados, M
Emery, P
Ferraccioli, G
Gabay, C
Gibofsky, A
Gomez-Reino, J
Jones, Graeme
Kvien, T
Murakami, M
Betteridge, N
Bingham, C
Bykerk, V
Choy, Ernest
Combe, B
Cutolo, M
Graninger, W
Lanas, A
Martin-Mola, E
Montecucco, C
Ostergaard, M
Pavelka, K
Rubbert-Roth, A
Sattar, N
Scholte-Voshaar, M
Tanaka, Y
Trauner, M
Valentini, G
Winthrop, K
de Wit, M
van der Heijde, D

April 2013

Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juvenile idiopath...

Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement

Schoels, Monika M
van der Heijde, Désirée
Breedveld, Ferdinand C
Burmester, Gerd R
Dougados, Maxime
Emery, Paul
Ferraccioli, Gianfranco
Gabay, Cem
Gibofsky, Allan
Gomez-Reino, Juan Jesus
Jones, Graeme
Kvien, Tore K
Murakami, Miho
Murikama, Miho M
Nishimoto, Norihiro
Smolen, Josef S

January 2013

Suppression of the immunoinflammatory cascade by targeting interleukin 6 (IL-6) mediated effects con...

Published Online First

Abstract

Extracted data

Published Online First

Abstract

Extracted data

Related items

Related items